Log in to save to my catalogue

The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times...

The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_389886546d264730a4787ef7cb840ff4

The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study

About this item

Full title

The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study

Publisher

England: BioMed Central Ltd

Journal title

Thrombosis journal, 2023-01, Vol.21 (1), p.4-4, Article 4

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Extracorporeal membrane oxygenation (ECMO) is applied in patients with respiratory or cardiopulmonary failure, but bleeding is a frequent complication contributing to the high mortality rates in this patient collective. A major factor predisposing patients to bleeding events is an acquired von Willebrand syndrome (aVWS). So far, specific treatment...

Alternative Titles

Full title

The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_389886546d264730a4787ef7cb840ff4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_389886546d264730a4787ef7cb840ff4

Other Identifiers

ISSN

1477-9560

E-ISSN

1477-9560

DOI

10.1186/s12959-022-00448-1

How to access this item